11. Exploratory INDs/CTAs

  1. Mitchell N. Cayen
  1. Mitchell N. Cayen

Published Online: 3 AUG 2010

DOI: 10.1002/9780470613191.ch11

Early Drug Development

Early Drug Development

How to Cite

Cayen, M. N. (2010) Exploratory INDs/CTAs, in Early Drug Development (ed M. N. Cayen), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470613191.ch11

Editor Information

  1. Cayen Pharmaceutical Consulting, LLC, Bedminster, New Jersey, USA

Author Information

  1. Cayen Pharmaceutical Consulting, LLC, Bedminster, New Jersey, USA

Publication History

  1. Published Online: 3 AUG 2010
  2. Published Print: 23 JUL 2010

ISBN Information

Print ISBN: 9780470170861

Online ISBN: 9780470613191

SEARCH

Keywords:

  • exploratory INDs/CTAs;
  • experience and various perspectives on ExpINDs or ExpCTAs;
  • ideal candidate for ExpIND/ExpCTA

Summary

This chapter contains sections titled:

  • Introduction

  • Regulatory Background

  • Experience and Various Perspectives on ExpINDs or ExpCTAs

  • Some Reactions and Perspectives on the ExpIND/ExpCTA Initiative

  • What Is an Ideal Candidate for an ExpIND/ExpCTA?

  • Conclusions

  • References